X-ZELL Company

Democratising cancer diagnostics by bringing digital single-cell analytics into routine cytology
Technology: Biomarkers of Female Cancers
Industry: Systemic
Headquarters: Singapore, Central Region, Singapore
Founded Date: 2014-12-01
Employees Number: 11-50
Funding Status: Seed
Investors Number: 13
Total Funding: $5,560,000.00
Estimated Revenue: $1M to $10M
Last Funding Date: 2018-05-01
Last Funding Type: Seed

Visit Website
Register and Claim Ownership